This conference brings together key stakeholders involved with clinical trials in Latin America. Latin America is an increasingly desirable location for running clinical trials, and it is important for those involved to collaborate with colleagues and industry counterparts regarding the challenges of developing, executing and completing clinical trials in Latin America.
This is a unique opportunity for pharmaceutical executives in Latin America to hear from key regulatory officials, pharmaceutical leaders, CROs and sites on how all stakeholders in the clinical process can ultimately achieve desired results.
This is an exceptional opportunity to improve upon clinical trials in this important market.
Conference Highlights include:
The Regulatory Framework — Hearing From Key Regulatory Stakeholders when Designing Clinical Trial Protocols
Panel of regulatory stakeholders from influential Latin American countries
Panel on collaboration with sponsor, CRO and regulatory officials to discuss how they can better work together and complement each other’s objectives to reach the ultimate goal of shortening approval times for clinical trials
Ethical Considerations when Conducting Clinical Trials in Latin America
Meeting independent Ethical Committee and IRB Standards
Improving Standards for Clinical Research Investigators in Latin America
Increasing public awareness of clinical trial research in Latin American countries
Matching Clinical Trial Protocol to Appropriate Sites
Training nascent sites to better prepare for clinical trials
Successful sponsor/CRO partnerships
Better understand what each site/principal investigator can provide with clinical trials
Enhancing the Latin American Image in the United States
Additional Sessions:
* proper handling of materials to Latin America
Sponsors/Exhibitors:
For more information or to register, please contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at cbireg@cbinet.com.
|